Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
27,148,200
-
Share change
-
+624,352
-
Total reported value
-
$135,208,154
-
Price per share
-
$4.98
-
Number of holders
-
51
-
Value change
-
+$3,489,821
-
Number of buys
-
31
-
Number of sells
-
19
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q1 2019
As of 31 Mar 2019,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,148,200 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, Broadfin Capital, LLC, ARMISTICE CAPITAL, LLC, Park West Asset Management LLC, Opaleye Management Inc., Hudson Bay Capital Management LP, SPHERA FUNDS MANAGEMENT LTD., Prosight Management, LP, and Vivo Capital, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.